Organoid technology attracts interest for personalized medicine, drug screening, and cell therapy. Assays with fragile organoid structures rely on manual handling, which limits the ability to perform complex assays easily, quickly, and reliably. In most cases, organoid formation is dependent on extracellular matrices (ECM).

Download this technical note to learn how to streamline complex multi-step procedures in organoid processing, courtesy of Protein Fluidics.